Prophylactic nailing of incomplete atypical femoral fractures
- PMID: 23365544
- PMCID: PMC3556877
- DOI: 10.1155/2013/450148
Prophylactic nailing of incomplete atypical femoral fractures
Abstract
Introduction: Recent reports have described the occurrence of low-energy subtrochanteric and femoral shaft fractures associated with long-term bisphosphonate use. Although information regarding the surgical treatment of these atypical femoral fractures is increasing, it is unclear if the preventive operation is useful in incomplete fractures. This study examined the results of preventive intramedullary nailing for incomplete atypical femoral fractures.
Material and methods: A retrospective search was conducted for patients older than 50 years receiving bisphosphonate therapy, with incomplete, nondisplaced fractures in either the subtrochanteric or diaphyseal area of the femur. Seventeen patients with a total of 20 incomplete, non-displaced lesions were included. The mean duration of bisphosphonate use was 50.5 months. Eleven of the 17 (64.7%) patients had complete or incomplete fractures on the contralateral femur. All were treated with prophylactic fixation of an intramedullary (IM) nail. The minimum followup was 12 months.
Results: All cases healed with a mean period of 14.3 weeks. Nineteen of the 20 cases healed with the dissolution of incomplete fractures of the lateral aspect. A complete fracture developed at the time of nailing in one patient, but it healed with callus bridging.
Conclusion: IM nailing appears to be a reliable way of preventing the progress of incomplete atypical femoral fractures.
Figures


Similar articles
-
Surgical strategy of the treatment of atypical femoral fractures.World J Orthop. 2023 May 18;14(5):302-311. doi: 10.5312/wjo.v14.i5.302. eCollection 2023 May 18. World J Orthop. 2023. PMID: 37304202 Free PMC article. Review.
-
Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.Clin Orthop Relat Res. 2014 Sep;472(9):2728-34. doi: 10.1007/s11999-013-2963-1. Clin Orthop Relat Res. 2014. PMID: 23604648 Free PMC article.
-
Surgical outcome of intramedullary nailing in patients with complete atypical femoral fracture: A multicenter retrospective study.Injury. 2017 Apr;48(4):941-945. doi: 10.1016/j.injury.2017.02.036. Epub 2017 Mar 1. Injury. 2017. PMID: 28274470
-
Incomplete Diaphyseal Atypical Femoral Fracture due to Increased Anterolateral Bowing: Treatment with Corrective Osteotomy and Intramedullary Nailing with Augmented Plate Fixation.J Bone Joint Surg Am. 2022 Dec 7;104(23):2059-2067. doi: 10.2106/JBJS.22.00363. Epub 2022 Oct 10. J Bone Joint Surg Am. 2022. PMID: 36215328
-
Does fracture affect the healing time or frequency of recurrence in a simple bone cyst of the proximal femur?Clin Orthop Relat Res. 2014 Oct;472(10):3166-76. doi: 10.1007/s11999-014-3768-6. Epub 2014 Jul 8. Clin Orthop Relat Res. 2014. PMID: 25002216 Free PMC article.
Cited by
-
Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis.Case Rep Orthop. 2018 Sep 20;2018:7862516. doi: 10.1155/2018/7862516. eCollection 2018. Case Rep Orthop. 2018. PMID: 30402317 Free PMC article.
-
Surgical strategy of the treatment of atypical femoral fractures.World J Orthop. 2023 May 18;14(5):302-311. doi: 10.5312/wjo.v14.i5.302. eCollection 2023 May 18. World J Orthop. 2023. PMID: 37304202 Free PMC article. Review.
-
Intramedullary Nailing: Definitive as well as Prophylactic Fixation Method in a Case of Bilateral Atypical Femoral Fractures - A Case Report.J Orthop Case Rep. 2019;9(3):61-64. doi: 10.13107/jocr.2250-0685.1422. J Orthop Case Rep. 2019. PMID: 31559230 Free PMC article.
-
Combined Effect of a Locking Plate and Teriparatide for Incomplete Atypical Femoral Fracture: Two Case Reports of Curved Femurs.Case Rep Orthop. 2015;2015:213614. doi: 10.1155/2015/213614. Epub 2015 May 26. Case Rep Orthop. 2015. PMID: 26101679 Free PMC article.
-
Epidemiology and Postoperative Outcomes of Atypical Femoral Fractures in Older Adults: A Systematic Review.J Nutr Health Aging. 2017;21(1):83-91. doi: 10.1007/s12603-015-0652-3. J Nutr Health Aging. 2017. PMID: 27999854
References
-
- Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. The New England Journal of Medicine. 1995;333(22):1437–1443. - PubMed
-
- Napoli N, Novack D, Armamento-Villareal R. Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies. Osteoporosis International. 2010;21(4):705–708. - PubMed
-
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. The Lancet. 1996;348(9041):1535–1541. - PubMed
-
- Black DM, Thompson DE, Bauer DC, et al. Erratum: fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. FIT Research Group. Journal of Clinical Endocrinology and Metabolism. 2000;85(11):4118–4124. - PubMed
-
- Goh SK, Yang KY, Koh JSB, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. Journal of Bone and Joint Surgery B. 2007;89(3):349–353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical